Glioma Treatment Market, Global Outlook and Forecast 2022-2028

August 2022 | 67 pages | ID: GA06E69519E2EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Glioma Treatment in Global, including the following market information:

Global Glioma Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Glioma Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Radiation Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Glioma Treatment include Sun Pharmaceutical Industries, Amgen, Teva Pharmaceutical Industries, Bristol-Myers Squibb, Pfizer, Merck KGaA and F. Hoffmann-La Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glioma Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Glioma Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Glioma Treatment Market Segment Percentages, by Type, 2021 (%)

• Radiation Therapy
• Targeted Drug Therapy
• Other

Global Glioma Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Glioma Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Other

Global Glioma Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Glioma Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Glioma Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Glioma Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sun Pharmaceutical Industries
• Amgen
• Teva Pharmaceutical Industries
• Bristol-Myers Squibb
• Pfizer
• Merck KGaA
• F. Hoffmann-La Roche

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Glioma Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Glioma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GLIOMA TREATMENT OVERALL MARKET SIZE

2.1 Global Glioma Treatment Market Size: 2021 VS 2028
2.2 Global Glioma Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Glioma Treatment Players in Global Market
3.2 Top Global Glioma Treatment Companies Ranked by Revenue
3.3 Global Glioma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Glioma Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Glioma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Glioma Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Glioma Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Glioma Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Glioma Treatment Market Size Markets, 2021 & 2028
  4.1.2 Radiation Therapy
  4.1.3 Targeted Drug Therapy
  4.1.4 Other
4.2 By Type - Global Glioma Treatment Revenue & Forecasts
  4.2.1 By Type - Global Glioma Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Glioma Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Glioma Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Glioma Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Other
5.2 By Application - Global Glioma Treatment Revenue & Forecasts
  5.2.1 By Application - Global Glioma Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Glioma Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Glioma Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Glioma Treatment Market Size, 2021 & 2028
6.2 By Region - Global Glioma Treatment Revenue & Forecasts
  6.2.1 By Region - Global Glioma Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Glioma Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Glioma Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Glioma Treatment Revenue, 2017-2028
  6.3.2 US Glioma Treatment Market Size, 2017-2028
  6.3.3 Canada Glioma Treatment Market Size, 2017-2028
  6.3.4 Mexico Glioma Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Glioma Treatment Revenue, 2017-2028
  6.4.2 Germany Glioma Treatment Market Size, 2017-2028
  6.4.3 France Glioma Treatment Market Size, 2017-2028
  6.4.4 U.K. Glioma Treatment Market Size, 2017-2028
  6.4.5 Italy Glioma Treatment Market Size, 2017-2028
  6.4.6 Russia Glioma Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Glioma Treatment Market Size, 2017-2028
  6.4.8 Benelux Glioma Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Glioma Treatment Revenue, 2017-2028
  6.5.2 China Glioma Treatment Market Size, 2017-2028
  6.5.3 Japan Glioma Treatment Market Size, 2017-2028
  6.5.4 South Korea Glioma Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Glioma Treatment Market Size, 2017-2028
  6.5.6 India Glioma Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Glioma Treatment Revenue, 2017-2028
  6.6.2 Brazil Glioma Treatment Market Size, 2017-2028
  6.6.3 Argentina Glioma Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Glioma Treatment Revenue, 2017-2028
  6.7.2 Turkey Glioma Treatment Market Size, 2017-2028
  6.7.3 Israel Glioma Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Glioma Treatment Market Size, 2017-2028
  6.7.5 UAE Glioma Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sun Pharmaceutical Industries
  7.1.1 Sun Pharmaceutical Industries Corporate Summary
  7.1.2 Sun Pharmaceutical Industries Business Overview
  7.1.3 Sun Pharmaceutical Industries Glioma Treatment Major Product Offerings
  7.1.4 Sun Pharmaceutical Industries Glioma Treatment Revenue in Global Market (2017-2022)
  7.1.5 Sun Pharmaceutical Industries Key News
7.2 Amgen
  7.2.1 Amgen Corporate Summary
  7.2.2 Amgen Business Overview
  7.2.3 Amgen Glioma Treatment Major Product Offerings
  7.2.4 Amgen Glioma Treatment Revenue in Global Market (2017-2022)
  7.2.5 Amgen Key News
7.3 Teva Pharmaceutical Industries
  7.3.1 Teva Pharmaceutical Industries Corporate Summary
  7.3.2 Teva Pharmaceutical Industries Business Overview
  7.3.3 Teva Pharmaceutical Industries Glioma Treatment Major Product Offerings
  7.3.4 Teva Pharmaceutical Industries Glioma Treatment Revenue in Global Market (2017-2022)
  7.3.5 Teva Pharmaceutical Industries Key News
7.4 Bristol-Myers Squibb
  7.4.1 Bristol-Myers Squibb Corporate Summary
  7.4.2 Bristol-Myers Squibb Business Overview
  7.4.3 Bristol-Myers Squibb Glioma Treatment Major Product Offerings
  7.4.4 Bristol-Myers Squibb Glioma Treatment Revenue in Global Market (2017-2022)
  7.4.5 Bristol-Myers Squibb Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Glioma Treatment Major Product Offerings
  7.5.4 Pfizer Glioma Treatment Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Merck KGaA
  7.6.1 Merck KGaA Corporate Summary
  7.6.2 Merck KGaA Business Overview
  7.6.3 Merck KGaA Glioma Treatment Major Product Offerings
  7.6.4 Merck KGaA Glioma Treatment Revenue in Global Market (2017-2022)
  7.6.5 Merck KGaA Key News
7.7 F. Hoffmann-La Roche
  7.7.1 F. Hoffmann-La Roche Corporate Summary
  7.7.2 F. Hoffmann-La Roche Business Overview
  7.7.3 F. Hoffmann-La Roche Glioma Treatment Major Product Offerings
  7.7.4 F. Hoffmann-La Roche Glioma Treatment Revenue in Global Market (2017-2022)
  7.7.5 F. Hoffmann-La Roche Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Glioma Treatment Market Opportunities & Trends in Global Market
Table 2. Glioma Treatment Market Drivers in Global Market
Table 3. Glioma Treatment Market Restraints in Global Market
Table 4. Key Players of Glioma Treatment in Global Market
Table 5. Top Glioma Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Glioma Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Glioma Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Glioma Treatment Product Type
Table 9. List of Global Tier 1 Glioma Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glioma Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Glioma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Glioma Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Glioma Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Glioma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Glioma Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Glioma Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Glioma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Glioma Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Glioma Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Glioma Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Glioma Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Glioma Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Glioma Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Glioma Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Glioma Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Glioma Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Glioma Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Glioma Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Glioma Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Sun Pharmaceutical Industries Corporate Summary
Table 31. Sun Pharmaceutical Industries Glioma Treatment Product Offerings
Table 32. Sun Pharmaceutical Industries Glioma Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Amgen Corporate Summary
Table 34. Amgen Glioma Treatment Product Offerings
Table 35. Amgen Glioma Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Teva Pharmaceutical Industries Corporate Summary
Table 37. Teva Pharmaceutical Industries Glioma Treatment Product Offerings
Table 38. Teva Pharmaceutical Industries Glioma Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Bristol-Myers Squibb Corporate Summary
Table 40. Bristol-Myers Squibb Glioma Treatment Product Offerings
Table 41. Bristol-Myers Squibb Glioma Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Glioma Treatment Product Offerings
Table 44. Pfizer Glioma Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Merck KGaA Corporate Summary
Table 46. Merck KGaA Glioma Treatment Product Offerings
Table 47. Merck KGaA Glioma Treatment Revenue (US$, Mn), (2017-2022)
Table 48. F. Hoffmann-La Roche Corporate Summary
Table 49. F. Hoffmann-La Roche Glioma Treatment Product Offerings
Table 50. F. Hoffmann-La Roche Glioma Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Glioma Treatment Segment by Type in 2021
Figure 2. Glioma Treatment Segment by Application in 2021
Figure 3. Global Glioma Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Glioma Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Glioma Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Glioma Treatment Revenue in 2021
Figure 8. By Type - Global Glioma Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Glioma Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Glioma Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Glioma Treatment Revenue Market Share, 2017-2028
Figure 12. US Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Glioma Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Glioma Treatment Revenue Market Share, 2017-2028
Figure 24. China Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Glioma Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Glioma Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Glioma Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Sun Pharmaceutical Industries Glioma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amgen Glioma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Teva Pharmaceutical Industries Glioma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bristol-Myers Squibb Glioma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Glioma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck KGaA Glioma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. F. Hoffmann-La Roche Glioma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)